Expert committee recommends voluntary license, technology transfer for production of Kovid vaccine – expert committee recommends transfer of voluntary license technology for production of kovid vaccine
This recommendation has been made in the midst of a proposal to temporarily exempt certain provisions of the TRIPS Agreement to deal with the growing epidemic of India and South Africa.
It is noteworthy that India and South Africa have suggested exemption from certain provisions of the TRIPS Agreement for all WTO member countries in October 2020 regarding prevention and treatment of Kovid-19.
The Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS) came into force in January 1995. It is a multilateral agreement on intellectual property rights such as copyright, industrial design, patents.
A committee of independent experts reviewing the World Health Organization’s (WHO) response to the corona virus pandemic said that major vaccine producers are in agreement to create a consensus for voluntary licensing and technology transfer to the WTO and WHO for covid-19 vaccines. A meeting of countries and manufacturers should be called.
Among the experts, former New Zealand Prime Minister Helen Clarke and Liberia’s former President Elaine Johnson said that if steps in this direction are not taken within three months, the exemption from intellectual property rights under the TRIPS Agreement should come into effect immediately.
The total 13-member committee also includes Preeti Sudan, former health secretary of India.
The committee of experts, in its recommendation, said that high-income countries, which have a sufficient number of vaccines available for their citizens or are in the pipeline, should increase production to 92 low and middle-income countries by September 1, 2021. Commitment should be made to provide at least one billion vaccine doses and more than two billion doses by mid-2022.
The report also stated that Serum Institute of India, Cyanopharm in China and Gamalaya Research in Russia could be important companies in the world in terms of increasing vaccine production units.
#Expert #committee #recommends #voluntary #license #technology #transfer #production #Kovid #vaccine #expert #committee #recommends #transfer #voluntary #license #technology #production #kovid #vaccine